These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2893653)

  • 1. Intrathecal dynorphin A1-13 and dynorphin A3-13 reduce rat spinal cord blood flow by non-opioid mechanisms.
    Long JB; Kinney RC; Malcolm DS; Graeber GM; Holaday JW
    Brain Res; 1987 Dec; 436(2):374-9. PubMed ID: 2893653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal dynorphin A (1-13) and (3-13) reduce spinal cord blood flow by non-opioid mechanisms.
    Long JB; Kinney RC; Malcolm DS; Graeber GM; Holaday JW
    NIDA Res Monogr; 1986; 75():524-6. PubMed ID: 2893280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function.
    Long JB; Petras JM; Mobley WC; Holaday JW
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1167-74. PubMed ID: 2901487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
    Long JB; Mobley WC; Holaday JW
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism.
    Rochford J; Godin C; Henry JL
    Brain Res; 1991 Nov; 565(1):67-77. PubMed ID: 1685349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury.
    Faden AI
    Ann Neurol; 1990 Jan; 27(1):67-74. PubMed ID: 1967925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.
    Knox RJ; Dickenson AH
    Brain Res; 1987 Jul; 415(1):21-9. PubMed ID: 2887243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous opioids in spinal cord injury: a critical evaluation.
    Long JB; Martinez-Arizala A; Petras JM; Holaday JW
    Cent Nerv Syst Trauma; 1986; 3(4):295-315. PubMed ID: 2884046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphin-A-(1-13) antagonizes morphine analgesia in the brain and potentiates morphine analgesia in the spinal cord.
    Ren MF; Lu CH; Han JS
    Peptides; 1985; 6(6):1015-20. PubMed ID: 2871545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine8-vasopressin reduces spinal cord blood flow after spinal subarachnoid injection in rats.
    Long JB; Martinez-Arizala A; Johnson SH; Holaday JW
    J Pharmacol Exp Ther; 1989 May; 249(2):499-506. PubMed ID: 2524587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of the analgesic and paralytic effects induced by intrathecal dynorphin a in rats.
    Xue JC; Yu YX; Han JS; Jen MF
    Int J Neurosci; 1995 May; 82(1-2):83-93. PubMed ID: 7591518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal dynorphins suppress hindlimb electromyographic activity in rats.
    Stevens CW; Weinger MB; Yaksh TL
    Eur J Pharmacol; 1987 Jun; 138(2):299-302. PubMed ID: 2887441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal dynorphin A administration causes pressor responses in rats associated with an increased resistance to spinal cord blood flow.
    Thornhill JA; Gregor L; Mathison R; Pittman Q
    Brain Res; 1989 Jun; 490(1):174-7. PubMed ID: 2569352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of dynorphin A-induced antinociception at spinal level.
    Spampinato S; Candeletti S
    Eur J Pharmacol; 1985 Mar; 110(1):21-30. PubMed ID: 2861098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynorphins other than dynorphin A(1-17) lack spinal antianalgesic activity but do act on dynorphin A(1-17) receptors.
    Rady JJ; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1073-80. PubMed ID: 1684812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nociceptin and dynorphin A(1-17) produce antianalgesia through independent systems in mice.
    Rady JJ; Fujimoto JM
    Life Sci; 2002 Jan; 70(9):1085-93. PubMed ID: 11860156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin A-(1-17) induces alterations in free fatty acids, excitatory amino acids, and motor function through an opiate-receptor-mediated mechanism.
    Bakshi R; Newman AH; Faden AI
    J Neurosci; 1990 Dec; 10(12):3793-800. PubMed ID: 1980130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrastriatal injections of dynorphin A fragments potentiate the dorsal immobility response in rats.
    Meyer ME
    Pharmacol Biochem Behav; 1993 Feb; 44(2):329-32. PubMed ID: 8095341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.
    Faden AI; Jacobs TP
    Br J Pharmacol; 1984 Feb; 81(2):271-6. PubMed ID: 6142741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 release evoked by intrathecal dynorphin is dependent on spinal p38 mitogen activated protein kinase.
    Svensson CI; Hua XY; Powell HC; Lai J; Porreca F; Yaksh TL
    Neuropeptides; 2005 Oct; 39(5):485-94. PubMed ID: 16176831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.